London, UK - The European Medicines Agency has recommended restricting the use of cilostazol-containing medicines in the treatment of intermittent claudication to a narrower patient population in ...

Please provide your email address to receive an email when new articles are posted on . Use of cilostazol after lower-extremity revascularization was associated with improved amputation-free survival ...

Please provide your email address to receive an email when new articles are posted on . Patients with peripheral artery disease on hemodialysis had a significantly reduced risk for major adverse CV ...

Triple antiplatelet therapy consisting of cilostazol added to clopidogrel and aspirin does not improve clinical outcomes in patients who receive drug-eluting stents (DES) compared with standard dual ...

Triple antiplatelet therapy with cilostazol results in lower in-stent restenosis (ISR) after drug-eluting stent (DES) implantation compared with dual therapy in patients with stent lengths greater ...

The European Medicines Agency has recommended restricting the use of cilostazol-containing medicines in the treatment of intermittent claudication to a narrower patient population in which there are ...